ID

13749

Descripción

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01074047

Link

https://clinicaltrials.gov/show/NCT01074047

Palabras clave

Versiones (1)
  1. 2/3/16 2/3/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

2 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Myeloid Leukemia NCT01074047

Inglés

Eligibility Acute Myeloid Leukemia NCT01074047

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of one of the following
Descripción

ID.1

Tipo de datos

boolean

newly diagnosed de novo acute myeloid leukemia (aml)
Descripción

newly diagnosed de novo acute myeloid leukemia (aml)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1515568
aml secondary to myelodysplastic syndromes (mds)
Descripción

aml secondary to myelodysplastic syndromes (mds)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0280449
UMLS CUI [2]
C3463824
aml secondary to exposure to leukemogenic therapy or agents with primary malignancy in remission for at least 2 years
Descripción

aml secondary to exposure to leukemogenic therapy or agents with primary malignancy in remission for at least 2 years

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0280449
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C2983796
bone marrow blasts >30%
Descripción

bone marrow blasts >30%

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1982687
age ≥ 65 years
Descripción

age ≥ 65 years

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
easter cooperative oncology group (ecog) 0-2
Descripción

easter cooperative oncology group (ecog) 0-2

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous cytotoxic or biologic treatment for aml (except hydroxyurea)
Descripción

previous cytotoxic or biologic treatment for aml (except hydroxyurea)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1514463
UMLS CUI [2]
C0020402
previous treatment with azacitidine, decitabine or cytarabine
Descripción

previous treatment with azacitidine, decitabine or cytarabine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004475
UMLS CUI [1,2]
C1514463
UMLS CUI [2,1]
C0049065
UMLS CUI [2,2]
C1514463
UMLS CUI [3,1]
C0010711
UMLS CUI [3,2]
C1514463
prior use of targeted therapy agents (e.g., flt3 inhibitors, other kinase inhibitors)
Descripción

prior use of targeted therapy agents (e.g., flt3 inhibitors, other kinase inhibitors)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C1514463
aml french american british subtype (fab m3)
Descripción

aml french american british subtype (fab m3)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023487
aml associated with inv(16), t(8;21), t(16;16), t(15:17), or t(9;22) karyotypes
Descripción

aml associated with inv(16), t(8;21), t(16;16), t(15:17), or t(9;22) karyotypes

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0008625
prior bone marrow or stem cell transplantation
Descripción

prior bone marrow or stem cell transplantation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005961
UMLS CUI [1,2]
C0332152
UMLS CUI [2,1]
C1504389
UMLS CUI [2,2]
C0332152
candidate for allogeneic bone marrow or stem cell transplant
Descripción

candidate for allogeneic bone marrow or stem cell transplant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005961
UMLS CUI [2]
C1504389
diagnosis of malignant disease within the previous 12 months (excluding base cell carcinoma, "in-situ" carcinoma of the cervix or breast or other local malignancy excised or irradiated with a high probability of cure)
Descripción

diagnosis of malignant disease within the previous 12 months (excluding base cell carcinoma, "in-situ" carcinoma of the cervix or breast or other local malignancy excised or irradiated with a high probability of cure)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
malignant hepatic tumors
Descripción

malignant hepatic tumors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0345904
uncontrolled systemic infection
Descripción

uncontrolled systemic infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3646020
active viral infection with human immunodeficiency virus (hiv) or hepatitis type b or c
Descripción

active viral infection with human immunodeficiency virus (hiv) or hepatitis type b or c

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019682
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
use of any experimental drug or therapy within 28 days prior to day 1
Descripción

use of any experimental drug or therapy within 28 days prior to day 1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0304229
Volver a la parte superior de la página

Similar models

Eligibility Acute Myeloid Leukemia NCT01074047

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diagnosis of one of the following
boolean
de novo aml
Item
newly diagnosed de novo acute myeloid leukemia (aml)
boolean
C0023467 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
secondary AML
Item
aml secondary to myelodysplastic syndromes (mds)
boolean
C0280449 (UMLS CUI [1])
C3463824 (UMLS CUI [2])
secondary aml to leukemogenic therapy
Item
aml secondary to exposure to leukemogenic therapy or agents with primary malignancy in remission for at least 2 years
boolean
C0280449 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C2983796 (UMLS CUI [2,2])
bone marrow blasts
Item
bone marrow blasts >30%
boolean
C1982687 (UMLS CUI [1])
age
Item
age ≥ 65 years
boolean
C0001779 (UMLS CUI [1])
ECOG
Item
easter cooperative oncology group (ecog) 0-2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
prior therapy for aml
Item
previous cytotoxic or biologic treatment for aml (except hydroxyurea)
boolean
C0023467 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0020402 (UMLS CUI [2])
previous treatment with azacitidine, decitabine or cytarabine
Item
previous treatment with azacitidine, decitabine or cytarabine
boolean
C0004475 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0049065 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C0010711 (UMLS CUI [3,1])
C1514463 (UMLS CUI [3,2])
prior use of targeted therapy agents
Item
prior use of targeted therapy agents (e.g., flt3 inhibitors, other kinase inhibitors)
boolean
C2985566 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
AML m3
Item
aml french american british subtype (fab m3)
boolean
C0023487 (UMLS CUI [1])
aml cytogenetics
Item
aml associated with inv(16), t(8;21), t(16;16), t(15:17), or t(9;22) karyotypes
boolean
C0023467 (UMLS CUI [1,1])
C0008625 (UMLS CUI [1,2])
prior bone marrow or stem cell transplantation
Item
prior bone marrow or stem cell transplantation
boolean
C0005961 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1504389 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
candidate for allogeneic bone marrow or stem cell transplant
Item
candidate for allogeneic bone marrow or stem cell transplant
boolean
C0005961 (UMLS CUI [1])
C1504389 (UMLS CUI [2])
malignant disease
Item
diagnosis of malignant disease within the previous 12 months (excluding base cell carcinoma, "in-situ" carcinoma of the cervix or breast or other local malignancy excised or irradiated with a high probability of cure)
boolean
C0006826 (UMLS CUI [1])
malignant neoplasm of the liver
Item
malignant hepatic tumors
boolean
C0345904 (UMLS CUI [1])
uncontrolled systemic infection
Item
uncontrolled systemic infection
boolean
C3646020 (UMLS CUI [1])
hiv, hepatitis b or c
Item
active viral infection with human immunodeficiency virus (hiv) or hepatitis type b or c
boolean
C0019682 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
experimental drug use
Item
use of any experimental drug or therapy within 28 days prior to day 1
boolean
C0304229 (UMLS CUI [1])
Volver a la parte superior de la página 

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial